Overview / Abstract: |
Dyslipidemia is one of the major risk factors for coronary artery disease, stroke, and peripheral vascular disease. Strategies for primary and secondary prevention have been developed and published by panels of experts and are intended to serve as guidelines for management of patients at various levels of risk for cardiovascular disease. This course reviews the guidelines for diagnosis and pharmacologic management of dyslipidemia in general and at-risk populations. Complex case studies are the basis for applying the current guidelines to the pharmacologic management of patients. Learning Objectives: 1. Describe the type of evidence upon which the 2013 ACC/AHA Blood Cholesterol guidelines were based; UAN: 0025-0000-15-171-H04-P |
Expiration |
Nov 12, 2018 |
Discipline(s) |
Pharmacy CPE |
Format |
Online, Webinar / Webcast / Video |
Cost |
$50.00 |
Credits / Hours |
2.0 Credit Hours |
Accreditation |
ACPE |
Presenters / Authors / Faculty |
David S. Roffman, PharmD, BCPS/Cardiology, Professor, University of Maryland School of Pharmacy |
Activity Specialities / Related Topics |
Dyslipidemia / Cholesterol |
Sponsors / Supporters / Grant Providers |
This course is sponsored in part by an educational grant from the Maryland Department of Health and Mental Hygiene and the Institute for a Healthiest Maryland. |
Keywords / Search Terms |
University of Maryland School of Pharmacy: CIPS Knowledge Enterprise CIPS, Knowledge Enterprise, Dyslipidemia, coronary artery disease, stroke, peripheral vascular disease, primary prevention, secondary prevention, cardiovascular disease, pharmacologic management of patients, |